interlaminar versus transforaminal infraneural approach for treatment of lumbar disc herniatio
Not Applicable
Completed
- Conditions
- Musculoskeletal DiseasesLow back pain
- Registration Number
- PACTR201611001878318
- Lead Sponsor
- Mansoura University hospitals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
single level or multi- level lumbar disc protrusion
with leg radiation of minimum 4 weeks duration
unrelieved by conventional treatment as well as physiotherapy
Exclusion Criteria
1.Patients with a history of backache without leg radiation,
2.Previous spine surgery,
3.LESI in the past months
4.Allergy to the drugs used,
5.Concurrent use of systemic steroid medications,
6.Opioid addiction
7.Pregnancy.
8.and patients with any neurological deficit will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the anti-inflammatory effects of interlaminar and transforaminal epidural steroids in lumbar disc herniation?
How does the interlaminar approach compare to transforaminal epidural steroids in managing radicular pain from intervertebral disc herniation?
Are there specific biomarkers that predict better outcomes with transforaminal versus interlaminar epidural steroid injections for lumbar disc herniation?
What are the potential adverse events associated with infraneural transforaminal epidural steroid injections in treating low back pain?
How do interlaminar and transforaminal epidural steroid interventions compare to surgical discectomy in long-term outcomes for lumbar disc herniation?